Biotricity Inc. (BTCY) Financial Statements (2026 and earlier)

Company Profile

Business Address 203 REDWOOD PARKWAY
REDWOOD CITY, CA 94065
State of Incorp. NV
Fiscal Year End March 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2025
MRQ
3/31/2025
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments36578657012,0672,202950
Cash and cash equivalent36578657012,0672,202950
Receivables1,6591,4691,2242,0071,521486
Inventory, net of allowances, customer advances and progress billings1,5551,8792,33784327286
Inventory1,5551,8792,33784327286
Deposits current assets1,060336589406327137
Total current assets:4,6394,4714,72015,3234,3221,659
Noncurrent Assets
Operating lease, right-of-use asset8121,2221,5871,24366264
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization10162227  
Long-term investments and receivables7115096   
Accounts and financing receivable, after allowance for credit loss7115096   
Deposits noncurrent assets109858585 33
Other undisclosed noncurrent assets     5048
Total noncurrent assets:1,0021,4721,7901,355116346
TOTAL ASSETS:5,6415,9436,51116,6784,4382,004
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:7,6629,6135,0422,5962,5201,522
Accounts payable4,6025,2223,4351,1591,0411,094
Accrued liabilities3,0344,3701,6071,4361,479428
Other undisclosed accounts payable and accrued liabilities2522    
Debt12,01911,6364,7741,5404,2782,068
Derivative instruments and hedges, liabilities4249921,0085213,634 
Other undisclosed current liabilities53145733621058213
Total current liabilities:20,63622,69911,1614,86710,4903,803
Noncurrent Liabilities
Long-term debt and lease obligation13,14210,85613,05013,603 57
Long-term debt, excluding current maturities13,14210,85613,05012,483  
Liabilities, other than long-term debt1,8772,3652,1463524101,145
Operating lease, liability 3989291,3861,120 57
Derivative instruments and hedges, liabilities1,4791,4367593524101,145
Other undisclosed noncurrent liabilities     371 
Total noncurrent liabilities:15,01913,22115,19513,9567811,202
Total liabilities:35,65535,91926,35618,82311,2715,005
Temporary equity, including noncontrolling interest      
Equity
Equity, attributable to parent, including:(32,014)(31,466)(19,845)(2,145)(6,833)(3,000)
Preferred stock  00 0
Common stock261053513936
Additional paid in capital106,97195,72392,80191,50756,29944,015
Accumulated other comprehensive income (loss)14632(153)(769)(634)(857)
Accumulated deficit(139,442)(127,500)(112,571)(93,037)(62,818)(46,364)
Warrants and rights outstanding      
Other undisclosed equity, attributable to parent28426925102281169
Other undisclosed equity 2,0001,489    
Total equity:(30,014)(29,977)(19,845)(2,145)(6,833)(3,000)
TOTAL LIABILITIES AND EQUITY:5,6415,9436,51116,6784,4382,004

Income Statement (P&L) ($ in thousands)

12/31/2025
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Revenues13,79012,0639,6397,6503,3851,418
Cost of revenue(3,226)(3,707)(4,197)(3,080)(1,871)(725)
Gross profit:10,5648,3565,4424,5701,514692
Operating expenses(13,013)(17,185)(20,852)(22,591)(14,865)(11,623)
Operating income (loss):(2,449)(8,828)(15,410)(18,020)(13,352)(10,931)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(79)(103)(111)15(37) 
Interest and debt expense(3,400)(264)(1,910)(380)1,200 
Loss from continuing operations before equity method investments, income taxes:(5,928)(9,195)(17,431)(18,385)(12,188)(10,931)
Other undisclosed income (loss) from continuing operations before income taxes(2,494)(4,900)(1,227)(10,746)(3,303)(136)
Loss from continuing operations:(8,421)(14,094)(18,658)(29,130)(15,491)(11,067)
Loss before gain (loss) on sale of properties:(29,130)(15,491)(11,067)
Net loss attributable to parent:(8,421)(14,094)(18,658)(29,130)(15,491)(11,067)
Preferred stock dividends and other adjustments(466)(835)(876)(1,089)(962)(258)
Other undisclosed net income (loss) available to common stockholders, basic (3,055)    0
Net loss available to common stockholders, diluted:(11,942)(14,929)(19,534)(30,219)(16,453)(11,325)

Comprehensive Income ($ in thousands)

12/31/2025
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Net loss:(8,421)(14,094)(18,658)(29,130)(15,491)(11,067)
Comprehensive loss:(8,421)(14,094)(18,658)(29,130)(15,491)(11,067)
Other undisclosed comprehensive loss, net of tax, attributable to parent(3,407)(650)(260)(1,223)(146,839)(360)
Comprehensive loss, net of tax, attributable to parent:(11,829)(14,744)(18,918)(30,354)(162,330)(11,427)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: